Phase 2 study of bosutinib, a Src inhibitor, in adults with recurrent glioblastoma. - Wikidata - awgldk - TriplyDB

Phase 2 study of bosutinib, a Src inhibitor, in adults with recurrent glioblastoma.

Phase 2 study of bosutinib, a Src inhibitor, in adults with recurrent glioblastoma.

http://www.wikidata.org/entity/Q35070978

about

New perspectives in glioblastoma antiangiogenic therapy Icariside II induces cell cycle arrest and apoptosis in human glioblastoma cells through suppressing Akt activation and potentiating FOXO3a activity.The importance of Src signaling in sarcoma.Novel Small Molecule JP-153 Targets the Src-FAK-Paxillin Signaling Complex to Inhibit VEGF-Induced Retinal Angiogenesis.Crossing the Blood-Brain Barrier: Recent Advances in Drug Delivery to the Brain.Src family kinases in chronic kidney disease.Micellar formulations of Crizotinib and Dasatinib in the management of glioblastoma multiforme.The Role of Class IA Phosphatidylinositol-4,5-Bisphosphate 3-Kinase Catalytic Subunits in Glioblastoma.

P2860

Q26746028-1DF56564-5569-4F58-96B0-9F824C281AC4 Q33733266-7AF9BF6C-9825-47E7-83A7-B71BD7C880A7 Q35802929-78805F8C-F7B3-4861-A956-73F8638A2B33 Q36212445-BE4EFAD2-1B40-4F52-9139-E1568C9BCF87 Q39013294-055DE235-6543-4909-A41C-CA384179C15E Q40159797-530AE90A-9DB1-4BFB-A70D-4CCC937AB6A3 Q47292301-070E990E-B5E5-404A-AF33-B2AAA37BA76B Q47868509-29AD2440-E525-445B-8EE9-43D4FF4FBC80

P2860

Phase 2 study of bosutinib, a Src inhibitor, in adults with recurrent glioblastoma.

http://www.wikidata.org/entity/Q35070978

description

2014 nî lūn-bûn

@nan

2014 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Phase 2 study of bosutinib, a Src inhibitor, in adults with recurrent glioblastoma.

@ast

Phase 2 study of bosutinib, a Src inhibitor, in adults with recurrent glioblastoma.

@en

type

label

Phase 2 study of bosutinib, a Src inhibitor, in adults with recurrent glioblastoma.

@ast

Phase 2 study of bosutinib, a Src inhibitor, in adults with recurrent glioblastoma.

@en

prefLabel

Phase 2 study of bosutinib, a Src inhibitor, in adults with recurrent glioblastoma.

@ast

Phase 2 study of bosutinib, a Src inhibitor, in adults with recurrent glioblastoma.

@en

P1433

Q35070978-C063CCF0-C974-4B49-9302-8AFBE90D6488

P1476

Q35070978-6CDF1A0C-F2D6-40A8-BF42-155D88747444

P2093

Q35070978-0E9697A1-098D-44B3-9920-45CD318DB042

Q35070978-19463C25-ACD0-4BE7-B2B3-74F04CA1301D

Q35070978-1DACA997-3463-47F8-BC3D-F169C451BE61

Q35070978-2D38C33F-CED0-4116-8F5F-7BCBB2A0DCB5

Q35070978-4416F748-F7EA-49FD-B990-6E606A84A835

Q35070978-5A395A37-03F8-4847-BAC2-7A3C4A29202B

Q35070978-5B79B2B2-1EB3-44EB-8AA5-97E2ABE36FF3

Q35070978-C51A0C8E-AFA0-48FB-85D8-00082C165563

Q35070978-C7595341-AA93-476C-AF82-D114A5BED39C

Q35070978-E306C9F7-A9DE-4523-BC68-7C0F4817459E

P2860

Q35070978-031C38CC-19C7-4224-8597-D5CD4F9A2458

Q35070978-20257A60-E767-4B91-8473-4552E7CC1724

Q35070978-26217F15-C777-44F5-95D2-804D533BFBEA

Q35070978-34A0F3AC-8E64-404F-9BA5-3076B28ED48E

Q35070978-37D44BBC-4736-4ACE-972F-BC13B5F8897C

Q35070978-579FE436-AA1D-49EE-96F2-02B3D1BF82CF

Q35070978-76FDBD43-E3EB-40D9-80F7-8D430E61B046

Q35070978-789B1B94-758B-490F-A68B-C2069BB5BDEE

Q35070978-78DB6F1E-40A8-4AA8-B469-F34E3D157FD2

Q35070978-82C3B9F4-4BBC-4218-915B-0E2DBF8A906B

P2888

Q35070978-3010AE1A-D5C4-4B3F-8CDC-0191900E5F22

P304

Q35070978-481885AD-A877-43B2-9CB0-EFCD9784D3AF

P31

Q35070978-21511D61-01D8-46C8-A45E-41412A0808BE

P356

Q35070978-C7FC4F88-A6F6-409B-9763-D07CF0A082A8

P433

Q35070978-4691F4D0-B7A6-4F32-9FED-CE263EEBAE7B

P478

Q35070978-E5E92616-0255-4050-ADA8-5F2C1D3C23A0

P50

Q35070978-1009FB4B-CF21-4420-9881-9E928E656572

P577

Q35070978-8C56F5A2-B421-462F-A7EA-ADCCC567424A

P698

Q35070978-8C758EEC-5EE0-469B-94B0-134BC3330BC1

P932

Q35070978-6DC4BACE-F47E-455A-BE0C-13590330DB1D

P356

S11060-014-1667-Z

P1433

Journal of Neuro-Oncology

P1476

Phase 2 study of bosutinib, a Src inhibitor, in adults with recurrent glioblastoma

@en

P2093

Alison E Randall

http://www.w3.org/2001/XMLSchema#string

Anat Stemmer-Rachamimov

http://www.w3.org/2001/XMLSchema#string

Andrew D Norden

http://www.w3.org/2001/XMLSchema#string

Andrew S Chi

http://www.w3.org/2001/XMLSchema#string

Diana H Giorgio

http://www.w3.org/2001/XMLSchema#string

Elizabeth R Gerstner

http://www.w3.org/2001/XMLSchema#string

Jennie W Taylor

http://www.w3.org/2001/XMLSchema#string

Jorg Dietrich

http://www.w3.org/2001/XMLSchema#string

Kellis Snodgrass

http://www.w3.org/2001/XMLSchema#string

Mikael L Rinne

http://www.w3.org/2001/XMLSchema#string

P2860

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

Bevacizumab alone and in combination with irinotecan in recurrent glioblastoma

Phase II trial of single-agent bevacizumab followed by bevacizumab plus irinotecan at tumor progression in recurrent glioblastoma

EORTC 26083 phase I/II trial of dasatinib in combination with CCNU in patients with recurrent glioblastoma.

Increased Src activity disrupts cadherin/catenin-mediated homotypic adhesion in human colon cancer and transformed rodent cells.

Safety and efficacy of bosutinib (SKI-606) in chronic phase Philadelphia chromosome-positive chronic myeloid leukemia patients with resistance or intolerance to imatinib

Phase I study of bosutinib, a src/abl tyrosine kinase inhibitor, administered to patients with advanced solid tumors.

Bosutinib versus imatinib in newly diagnosed chronic-phase chronic myeloid leukemia: results from the BELA trial.

In vitro and in vivo activity of SKI-606, a novel Src-Abl inhibitor, against imatinib-resistant Bcr-Abl+ neoplastic cells.

P2888

s11060-014-1667-z

P304

557-563

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11060-014-1667-Z

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

121

http://www.w3.org/2001/XMLSchema#string

P50

Daniel P Cahill

P577

2014-11-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25411098

http://www.w3.org/2001/XMLSchema#string

P932

4323868

http://www.w3.org/2001/XMLSchema#string